There are currently 6 active clinical trials seeking participants for Renal Impairment research studies. The states with the highest number of trials for Renal Impairment participants are Florida, California, Minnesota and Texas.
A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function
NCT05940402
Recruiting
The primary purpose of this study is to assess the effect of renal impairment on the pharmacokinetics (PK) of emraclidine following administration of a single oral dose in participants with mild, moderate, and severe renal impairment relative to matched participants with normal renal function.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/13/2024
Locations: Tustin, California, Tustin, California +4 locations
Conditions: Renal Impairment
Register for Updates
A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects With Severe Renal Impairment and Normal Renal Function
NCT04446507
Recruiting
This will be a Phase 1, Open-label Study of Participants with Normal Renal Function and Participants with Sever Renal Impairment.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
05/09/2024
Locations: DeLand Clinical Research Unit, DeLand, Florida +1 locations
Conditions: Renal Impairment
Register for Updates
A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
NCT05844228
Recruiting
The rationale of this study is to evaluate the impact of renal function on the PK, safety, and tolerability of VIR-2218 in participants with normal renal function and participants with varying degrees of renal dysfunction who are otherwise medically stable
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
05/01/2024
Locations: Inland Empire Clinical Trials, Rialto, California +2 locations
Conditions: Renal Impairment
Register for Updates
Study of GBT021601 in Participants With Renal Impairment
NCT05878704
Recruiting
Renal Impairment study of GBT021601.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/29/2024
Locations: Orange County Research Center, Lake Forest, California +3 locations
Conditions: Renal Impairment
Register for Updates
A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function
NCT06037031
Recruiting
The purpose of this study is to understand how the loss of kidney function affects study medicine (PF-07923568) in the body. People with some level of loss of kidney function may process PF-07923568 differently from healthy people. PF-07923568 is developed as a possible treatment for respiratory syncytial virus (RSV) infection. RSV is a common virus that affects the lungs and usually causes mild, cold-like symptoms. RSV can cause severe lung infections in infants, elderly, and adults with other... Read More
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
04/29/2024
Locations: Orlando Clinical Research Center, Orlando, Florida +4 locations
Conditions: Renal Impairment
Register for Updates
A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment
NCT05865171
Recruiting
The purpose of this study is to evaluate the pharmacokinetics and safety of a single dose of Inaxaplin (IXP) in participants with severe renal impairment and healthy participants with normal renal function.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
04/19/2024
Locations: Velocity Clinical Research, New Smyrna Beach, Edgewater, Florida +3 locations
Conditions: Renal Impairment
Register for Updates